Most listed pharmas re-appoint their CEO at the general meeting day
In the Stockholders’ Super General Meeting Day on March 16th, most CEOs with expired contract were reappointed.
Only did 2 companies – Chong Kun Dang Holdings and Sam Chun Damg Pharm – appoint a new CEO, but 10 pharmaceutical companies including Yuhan Corporation decided to remain their current ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
